WHO chief Tedros welcomes 'encouraging' news on COVID-19 vaccine from Pfizer, BioNTech

World Health Organization (WHO) chief Tedros ham Ghebreyesus hailed Pfizer and BioNTech's anuncement on Monday that vaccine y have jointly developed is 90% effective in preventing COVID-19 infection in ongoing Phase 3 trials.

Taking to Twitter, Dr Tedros welcomed ‘encouraging’ news and commended all scientists and partners engd in developing vaccine to beat Coronavirus.

A coronavirus vaccine may be rolled out by March 2021 to most vulnerable, which could fundamentally change course of pandemic, a senior World Health Organization (WHO) official said on Monday. dressing WHO's annual ministerial assembly, Bruce Aylward said that interim results from Pfizer Inc's phase-three vaccine trials were "very positive".

RE | Pfizer-BioNTech COVID-19 Vaccine Anuncement Rocks Global Stock Markets

Fauci hails ‘extraordinary’ Pfizer results

Anthony Fauci, top infectious-disease expert of US, said vaccine, being developed by Pfizer will have a “major impact" on battle against dely virus. Speaking to reporters, Fauci said, efficacy of Pfizer drug candidate being over 90% “is just extraordinary.” He asserted that Moderna may have similar results to Pfizer vaccine because it is also based on mRNA techlogy.

RE | 'Great Day For Science': COVID-19 Vaccine By Pfizer, BioNTech Shows More Than 90% Efficacy

Pfizer early trials show vaccine 90% effective

Earlier in day, American pharmaceutical Pfizer and its German partner BioNTech anunced ir Covid-19 vaccine candidate, BNT162b2, has prevented more than 90% of infections in a study involving thousands of volunteers in Phase 3 trials. This has been most encouraging scientific vancement so far in battle against Coronavirus.

Pfizer and BioNTech SE became first drugmakers to show promising results from a large-scale clinical trial of a Covid-19 vaccine. shots developed by two companies are among 10 possible vaccine candidates in late-st testing around world. As per reports, Pfizer has indicated that it will file an emergency use application with US regulators later this month.

RE | Pfizer, BioNTech Seek EUA As COVID-19 Vaccine Shows Over 90% Efficacy; Here's What's Next

RE | Joe Biden Cheers COVID-19 Vaccine Progress But Says Masks Remain A Must